VisionCare Ophthalmic Technologies News

Mr Martin was in Tasmania to present its subsidiary, Tasmanian Alkaloids' grower awards, and meet with farmers, members of the company and government representatives.

Johnson & Johnson, the world's biggest maker of health-care products, said it will stop selling metal-on-metal and ceramic-on-metal hip replacements as demand wanes for the devices and U.S. regulators seek new rules.

In Part I of "Johnson & Johnson: At The Crossroads", consideration was given to whether a dividend growth rate of 8.2% was sustainable if net income growth rate remained around the projected 6%. It was determined that this gap between dividend and net income growth rates was likely sustainable for at least the next 15 years.

Johnson & Johnson won U.S. approval to use its rheumatoid arthritis drug Simponi to treat patients suffering from a moderate to severe inflammatory bowel disease.

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Johnson & Johnson unit Janssen Research and Development LLC said the U.S. Food and Drug Administration has granted priority review to its new drug application for simeprevir, its investigational treatment of genotype 1 chronic hepatitis C in adult patients ... (more)

I'm not quite as fanatical as Warren, but I do enjoy digging into a company's annual report to learn something new.

It is putting in $30 million in a Band-Aid type ad campaign. This is the first time in a decade and its first global one ever that the company is indulging in a corporate re-brand ad campaign following recall of " millions of bottles and packages of Tylenol, Benadryl, Motrin and other over-the-counter medicines.

Patent expiration is one of the number one reasons for pharma companies' revenue deterioration.

If there was ever a stock that defined the buy and hold investment strategy it is Johnson & Johnson .

Weirdly, Guns N' Roses' "Sweet Child O' Mine" was recently softened as a nap-time lullaby for newborns.

If current projections for dividend growth rate remained at 8.2% per year and those for net income growth rate at ~6% per year, it was shown to be inevitable that the dividend payout ratio would continue to increase.

With a lot of market bubbles that crop up in various sectors, the results are usually disastrous.

Johnson & Johnson and its Cincinnati subsidiary, Ethicon Endo-Surgery, are benefiting from growing interest in obesity surgery in India, Bloomberg reports.

Anh is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.

Ethicon Endo-Surgery , a Johnson & Johnson company, announced that the FDA granted PMA approval for its SEDASYS device, the first computer-assisted personalized sedation system for use by clinicians in the endoscopy suites.

Nicholas is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.

"Is the writer getting anxious?" Betsey Johnson asks. Well, sort of. The interview was supposed to start 45 minutes ago, but the famed fashion designer and her daughter Lulu are still sequestered in the back of Lulu's apartment, getting their hair and makeup done for the photo shoot.

In March 2013, LifeScan, a division of Johnson & Johnson, announced a voluntary recall and replacement of approximately 90,000 blood glucose meters in the United States and nearly 2 million meters worldwide.

Investing in dividend growth stocks is a long-term proposition. One of the beauties of following a dividend growth strategy is that you don't have to watch your portfolio or the market on a daily basis.

Meena is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.